Predictors and complications of blood transfusion in rheumatoid arthritis patients undergoing total joint arthroplasty

Clin Rheumatol. 2023 Jan;42(1):67-73. doi: 10.1007/s10067-022-06376-9. Epub 2022 Sep 19.

Abstract

Purpose: Our research investigated predictors of postoperative blood transfusion rate following total joint arthroplasty (TJA) in patients with rheumatoid arthritis (RA) and evaluated the incidence of complications in the transfusion group and non-transfusion group.

Methods: The authors retrospectively analyzed risk factors among 320 RA patients who underwent elective total hip arthroplasty (THA) or total knee arthroplasty (TKA) from January 2010 to December 2018. Demographic characteristics, laboratory results, medication history, and surgical protocol were gathered from electronic medical records. Univariable and multivariable logistic regression analyses were conducted to measure the impact of relevant variables on the need for transfusions. In addition, we compared the incidence of complications associated with transfusion.

Results: The cohort comprised 320 RA patients, aged 57.4 ± 12.0 years, of whom 137 required postoperative blood transfusions and 183 did not. BMI, type of surgery, duration of surgery, disease activity score 28 (DAS28-CRP), tranexamic acid (TXA) administration, and preoperative hemoglobin (Hb) were all risk factors for transfusion after adjusting for the planned procedure.

Conclusion: Previously published predictors, such as BMI, low preoperative hemoglobin, duration of surgery, procedure type (THA), were also identified in our analysis. Moreover, TXA administration and the DAS28-CRP showed the potential to influence risk. The incidence of postoperative complications was increased in patients who received blood transfusions compared to non-transfusion group. Our findings could help to identify RA patient population requiring blood transfusions, to ensure the necessary steps are adopted to limit blood loss and improve blood management strategies. Key Points • The risk factors for blood transfusion in rheumatoid arthritis patients undergoing total joint arthroplasty were BMI, the type of surgery, duration of surgery, TXA administration, DAS28-CRP, and preoperative hemoglobin. • The incidence of postoperative complications was increased in patients who received blood transfusions compared to non-transfusion group.

Keywords: Blood transfusion; Rheumatoid arthritis; Total joint arthroplasty.

MeSH terms

  • Antifibrinolytic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Arthroplasty, Replacement, Hip* / adverse effects
  • Blood Loss, Surgical
  • Blood Transfusion
  • Hemoglobins
  • Humans
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Retrospective Studies
  • Tranexamic Acid* / therapeutic use

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid
  • Hemoglobins